NCT00882687View on ClinicalTrials.gov

Efficacy Study to Evaluate the Effectiveness of 3 Concentrations of SAR 1118 in Allergic Conjunctivitis

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 24, 2009

Primary Completion Date

May 10, 2009

Study Completion Date

May 10, 2009

Conditions
Allergic Conjunctivitis
Interventions
DRUG

Lifitegrast

Ophthalmic Solution

OTHER

Placebo

Ophthalmic Solution

Trial Locations (1)

01810

Ora, Andover

Sponsors

Lead Sponsor

Shire
All Listed Sponsors
lead

Shire

INDUSTRY

NCT00882687 - Efficacy Study to Evaluate the Effectiveness of 3 Concentrations of SAR 1118 in Allergic Conjunctivitis | Biotech Hunter | Biotech Hunter